Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 69.90
-1.40 (-1.96%)
At close: Jul 9, 2026
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 4.9 billion as of July 9, 2026. Its market cap has increased by 35.92% in one year.
Market Cap
4.90B
Enterprise Value
3.87B
Revenue
47.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
69.90
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 4.90B, an increase of 158.02%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 4.90B | 75.66% |
| Dec 31, 2025 | 2.79B | -17.68% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 5.53B |
| Mycenax Biotech | 5.48B |
| Medigen Biotechnology | 5.33B |
| UnicoCell Biomed | 5.18B |
| Steminent Biotherapeutics | 4.93B |
| Pharmosa Biopharm | 4.91B |
| OBI Pharma | 3.94B |
| Senhwa Biosciences | 3.91B |